Home Mf Research Icici Prudential Healthcare Fund Regular Plan Growth
ICICI Prudential Mutual Fund

Mutual Fund Research

ICICI Prudential Healthcare Fund - Regular Plan - Growth

Fund Performance

-
-
Historical NAV
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • SI

SIP Returns

Historical performance of a ₹1,000 monthly SIP

Historical data
Investment Period SIP Start Date Amount Invested Current Value Absolute Return
One Week 2026-10-27 ₹1,000.00 ₹1,028.06 +2.81%
Two Week 2026-10-19 ₹1,000.00 ₹1,041.16 +4.12%
One Month 2026-10-05 ₹1,000.00 ₹1,015.29 +1.53%
Three Months 2026-08-05 ₹3,000.00 ₹2,966.47 -1.12%
Six Months 2026-05-07 ₹6,000.00 ₹6,005.67 +0.09%
One Year 2025-11-03 ₹12,000.00 ₹12,604.08 +5.03%
Three Year 2023-11-06 ₹36,000.00 ₹42,614.32 +18.37%
Five Year 2021-11-08 ₹60,000.00 ₹94,128.63 +56.88%
Since Inception 2018-07-13 ₹102,000.00 ₹236,766.79 +132.12%

Past returns are historical, not guaranteed. SIP values depend on the dates and NAVs used.

Return Calculator

Explore SIP and one-time investment scenarios

₹1,000₹50,000
Investment Duration

Projection uses the selected fund return as an annualized assumption. It does not predict future performance.

Estimated Investment Summary

Investment
₹0
Maturity Value
₹0
Abs. Returns
₹0
Assumed Annual Return
0%

Illustrative values only. Market returns are not fixed or guaranteed.

Portfolio Allocation

Explore asset allocation, sector exposure and company holdings.

Equity
N/A
Debt
N/A
Others
N/A

Sector Allocation

Distribution across different sectors

Pharmaceuticals & Biotechnology 72.62%
Healthcare Services 18.28%
Retailing 5.05%
Chemicals & Petrochemicals 1.21%
Other 1.09%
Insurance 1.06%
Healthcare Equipment & Supplies 0.68%

Top Holdings

Company-wise portfolio exposure

Sun Pharmaceutical Industries Ltd. 11.49%
Dr. Reddy's Laboratories Ltd. 9.73%
Cipla Ltd. 5.79%
Biocon Ltd. 5.33%
Mankind Pharma Ltd. 5.04%
Alkem Laboratories Ltd. 4.81%
Medplus Health Services Ltd 4.31%
Cohance Lifesciences Ltd. 4.06%
Divi's Laboratories Ltd. 3.78%
Syngene International Ltd. 3.50%
Dr Agarwal's Health Care Ltd 2.66%
MAX Healthcare Institute Ltd 2.63%
Abbott India Ltd. 2.54%
Alembic Pharmaceuticals Ltd. 2.50%
Pfizer Ltd. 2.42%
Apollo Hospitals Enterprise Ltd. 2.30%
Gland Pharma Ltd. 1.97%
Akums Drugs and Pharmaceuticals Ltd. 1.91%
Lupin Ltd. 1.88%
Astrazeneca Pharma India Ltd. 1.85%
Blue Jet Healthcare Ltd. 1.83%
Indegene Ltd. 1.74%
Metropolis Healthcare Ltd. 1.65%
Rainbow Childrens Medicare Ltd 1.29%
Fine Organic Industries Ltd. 1.21%
Thyrocare Technologies Ltd. 1.17%
Aarti Drugs Ltd. 1.17%
Medi Assist Healthcare Services Ltd 1.06%
Alivus Life Sciences Ltd. 0.97%
Hikal Ltd. 0.95%
Sanofi Consumer Healthcare India Ltd 0.93%
Manipal Health Enterprises Ltd. 0.87%
Entero Healthcare Solutions 0.74%
Laxmi Dental Ltd. 0.68%
FDC Ltd. 0.66%
Windlas Biotech Ltd. 0.57%
Indraprastha Medical Corp Ltd 0.47%
Indoco Remedies Ltd. 0.43%
Natco Pharma Ltd. 0.02%
TREPS 4.25%
Cash Margin - Derivatives 0.01%
Net Current Assets -3.16%

Risk Ratios & Analysis

Understand the fund’s volatility, benchmark exposure and redemption characteristics.

σ
Standard Deviation
16.40%
Return volatility
β
Beta
0.96
Benchmark sensitivity
S
Sharpe Ratio
0.89
Risk-adjusted return
↗
Lock-in Period
N/A
Redemption restriction
◷
Residual Maturity
N/A
Time to maturity

Scheme Riskometer

Published risk classification for this scheme

Principal risk level

Investors understand that their principal will be at

Very High Risk

Low
Low to Moderate
Moderate
Moderately High
High
Very High

Riskometer is a scheme risk classification, not a prediction of future performance.

Fund Family

Compare schemes from ICICI Prudential Mutual Fund by performance, fundamentals and risk.

Returns are historical and do not guarantee future performance.

View All ICICI Prudential Mutual Fund Funds

Scheme Objective

The investment mandate and purpose of this scheme

To generate long term capital appreciation through investments made primarily in equity & equity related securities of companies forming part of Healthcare sector. However there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Scheme Details

Investment requirements and key fund information

Fund Information

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio (Regular)
2.08%
Expense Ratio (Direct)
1.32%
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE Healthcare TRI

Exit Load

Charges that may apply when you redeem units

1% of the applicable NAV - If units purchased or switched in from another scheme of the Fund are redeemed or switched out within 15 days from the date of allotment NIL - If units purchased or switched in from another scheme of the Fund are redeemed or switched out after 15 days from the date of allotment (w.e.f. 1st Jan 2019)

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?